Avoid common mistakes on your manuscript.
Dear Editor,
Iron deficiency anemia (IDA) is one of the most common nutritional diseases worldwide. The basic treatment for IDA is oral iron medication; however, some patients with IDA are occasionally refractory to this type of therapy [1]. Recently, the role of Helicobacter pylori in the etiology of IDA has become a focus of considerable interest [2, 3]. Although the association of H. pylori with IDA has been examined extensively, most studies have focused on mild IDA in school-aged children and young people [4–6]. Here, we report two adult cases of severe IDA refractory to oral iron therapy in which the anemia was dramatically and promptly improved by H. pylori eradication (Fig. 1).
A 73-year-old male was referred to our hospital because of severe anemia. He had been receiving oral iron (100 mg/day) therapy for more than 6 months, but his anemia had not improved significantly. Laboratory examinations revealed severe IDA (red blood cell count 269 × 1010/l, hemoglobin 4.7 g/dl, hematocrit 17.5 %, mean corpuscular volume 65.1 fl, mean corpuscular hemoglobin concentration 17.5 pg, serum iron 8 μg/dl, serum ferritin 4.7 ng/ml, unsaturated iron binding capacity 487 μg/dl). Endoscopic examination of the upper and lower gastrointestinal (GI) tract revealed mild atrophic gastritis with H. pylori infection, but no bleeding was detected in any part of the GI tract. A stool occult blood test gave a negative result. CT examination also revealed no abnormalities. Because oral iron therapy had failed in this patient, iron was administered intravenously, and this resulted in a gradual increase in the hemoglobin level. H. pylori eradication was performed using a standard regimen of amoxicillin, clarithromycin, and lansoprazole. Eradication was successful, and iron was then administered orally (100 mg/day). In contrast to the lack of response to oral iron therapy before H. pylori eradication, the patient’s hemoglobin level promptly increased to normal. Since discontinuation of iron therapy, IDA has not recurred for more than 3 years.
FormalPara Case 2A 36-year-old male was referred to our hospital because of severe IDA that was refractory to oral iron therapy. Laboratory examinations revealed the following values: red blood cell count 235 × 1010/l, hemoglobin 4.6 g/dl, hematocrit 17.0 %, mean corpuscular volume 72.3 fl, mean corpuscular hemoglobin concentration 19.6 pg, serum iron 10 μg/dl, serum ferritin 5.3 ng/ml, and unsaturated iron binding capacity 453 μg/dl. Endoscopic examination of the whole GI tract and CT scan revealed no abnormalities. Since H. pylori infection was detected, H. pylori eradication was performed. Similarly to the clinical course in case 1, IDA was promptly improved by oral iron administration. This patient also has shown no recurrence of IDA for more than 2 years after withdrawal of iron therapy.
Although an association between H. pylori infection and IDA has been established, it is still unknown how H. pylori mediates the pathogenesis of IDA. However, a number of possible mechanisms have been proposed, including impairment of gastric acidity by H. pylori infection [7]. Recently, it has been reported that H. pylori directly perturbs iron trafficking in epithelial cells [8, 9]. That is, CagA of H. pylori is able to alter the internalization, intracellular transport, and polarity of the transferrin/transferrin receptor iron uptake system [9]. The prompt improvement of iron adsorption observed after H. pylori eradication in the present two cases strongly suggests a direct interaction between H. pylori and iron transport. As it has also been reported that IDA accelerates H. pylori-induced carcinogenesis [10], H. pylori eradication is highly recommended in patients with IDA.
References
Hershko C, Camaschella C (2014) How I treat unexplained refractory iron deficiency anemia. Blood 123:326–333
Muhsen K, Cohen D (2008) Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 13:323–340
Cardenas VM, Mulla ZD, Ortiz M, Graham DY (2006) Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 163:127–134
Baggett HC, Parkinson AJ, Muth PT, Gold BD, Gessner BD (2006) Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics 117:e396–404
Muhsen K, Barak M, Henig C, Alpert G, Ornoy A, Cohen D (2010) Is the association between Helicobacter pylori infection and anemia age dependent? Helicobacter 15:467–472
Azab SF, Esh AM (2013) Serum hepcidin levels in Helicobacter pylori-infected children with iron-deficiency anemia: a case–control study. Ann Hematol 92:1477–1483
Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, Delle Fave G (2003) Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 52:496–501
Lee JH, Choe YH, Choi YO (2009) The expression of iron-repressible outer membrane proteins in Helicobacter pylori and its association with iron deficiency anemia. Helicobacter 14:36–39
Tan S, Noto JM, Romero-Gallo J, Peek RM Jr, Amieva MR (2011) Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog 7:e1002050
Noto JM, Gaddy JA, Lee JY et al (2013) Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest 123:479–492
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamanouchi, J., Azuma, T., Yakushijin, Y. et al. Dramatic and prompt efficacy of Helicobacter pylori eradication in the treatment of severe refractory iron deficiency anemia in adults. Ann Hematol 93, 1779–1780 (2014). https://doi.org/10.1007/s00277-014-2052-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-014-2052-x